PRRC1

gene
On this page

Also known as FLJ32875

Summary

PRRC1 (proline rich coiled-coil 1, HGNC:28164) is a protein-coding gene on chromosome 5q23.2, encoding Protein PRRC1 (Q96M27). May act as a regulator of the protein kinase A (PKA) activity during embryonic development.

Predicted to enable protein kinase A regulatory subunit binding activity. Predicted to be involved in epithelial structure maintenance. Predicted to be located in Golgi apparatus. Predicted to be active in cytoplasm.

Source: NCBI Gene 133619 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 96 total
  • MANE Select transcript: NM_130809

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28164
Approved symbolPRRC1
Nameproline rich coiled-coil 1
Location5q23.2
Locus typegene with protein product
StatusApproved
AliasesFLJ32875
Ensembl geneENSG00000164244
Ensembl biotypeprotein_coding
OMIM621301
Entrez133619

Gene structure

Transcript identifiers

Ensembl transcripts: 7 — 4 protein_coding, 2 retained_intron, 1 protein_coding_CDS_not_defined

ENST00000296666, ENST00000442138, ENST00000507774, ENST00000512635, ENST00000512871, ENST00000513427, ENST00000715263

RefSeq mRNA: 2 — MANE Select: NM_130809 NM_001286808, NM_130809

CCDS: CCDS4143, CCDS68943

Canonical transcript exons

ENST00000296666 — 9 exons

ExonStartEnd
ENSE00001082709127530294127530396
ENSE00001082712127526618127526778
ENSE00001082713127523460127523582
ENSE00001082714127533623127533786
ENSE00001082715127524531127524920
ENSE00001082716127547819127547921
ENSE00001082717127539040127539143
ENSE00004026362127551707127555085
ENSE00004026363127517640127517776

Expression profiles

Bgee: expression breadth ubiquitous, 283 present calls, max score 97.27.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 69.8304 / max 404.7280, expressed in 1822 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
5833452.37341817
5833516.39421804
583360.6527367
2036760.4101204

Top tissues by expression

301 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibiaUBERON:000097997.27gold quality
jejunal mucosaUBERON:000039996.23gold quality
secondary oocyteCL:000065595.39gold quality
stromal cell of endometriumCL:000225594.96gold quality
oocyteCL:000002394.84gold quality
islet of LangerhansUBERON:000000694.82gold quality
mucosa of sigmoid colonUBERON:000499394.77gold quality
palpebral conjunctivaUBERON:000181294.64gold quality
skin of hipUBERON:000155494.51gold quality
colonic mucosaUBERON:000031794.11gold quality
mammary ductUBERON:000176593.68gold quality
endometriumUBERON:000129593.63gold quality
eyeUBERON:000097093.39gold quality
upper leg skinUBERON:000426293.36gold quality
corpus epididymisUBERON:000435993.18gold quality
tendon of biceps brachiiUBERON:000818892.99gold quality
mucosa of paranasal sinusUBERON:000503092.84gold quality
placentaUBERON:000198792.68gold quality
germinal epithelium of ovaryUBERON:000130492.66gold quality
epithelium of nasopharynxUBERON:000195192.63gold quality
nasopharynxUBERON:000172892.62gold quality
cartilage tissueUBERON:000241892.62gold quality
cauda epididymisUBERON:000436092.50gold quality
caput epididymisUBERON:000435892.49gold quality
adrenal tissueUBERON:001830392.44gold quality
oral cavityUBERON:000016792.22gold quality
nippleUBERON:000203092.19gold quality
penisUBERON:000098992.14gold quality
amniotic fluidUBERON:000017392.12gold quality
parietal pleuraUBERON:000240091.92gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes9.33

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

197 targeting PRRC1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-656-3P100.0072.152788
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-5692A100.0074.406850
HSA-MIR-1252-5P100.0069.802774
HSA-MIR-518D-5P100.0067.51979
HSA-MIR-518E-5P100.0067.66954
HSA-MIR-518F-5P100.0067.51979
HSA-MIR-519A-5P100.0067.66954
HSA-MIR-519B-5P100.0067.66954
HSA-MIR-519C-5P100.0067.66954
HSA-MIR-520C-5P100.0067.51979
HSA-MIR-522-5P100.0067.66954
HSA-MIR-523-5P100.0067.66954
HSA-MIR-526A-5P100.0067.51979
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-4262100.0073.263931
HSA-MIR-4510100.0066.602050
HSA-MIR-6127100.0066.762188
HSA-MIR-6129100.0066.462080
HSA-MIR-6130100.0066.692012
HSA-MIR-6133100.0066.482064
HSA-MIR-4668-3P100.0068.742635
HSA-MIR-340-5P100.0072.504437

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioprrc1ENSDARG00000044304
mus_musculusPrrc1ENSMUSG00000024594
rattus_norvegicusPrrc1ENSRNOG00000016433
caenorhabditis_elegansWBGENE00015454

Protein

Protein identifiers

Protein PRRC1Q96M27 (reviewed: Q96M27)

Alternative names: Proline-rich and coiled-coil-containing protein 1

All UniProt accessions (1): Q96M27

UniProt curated annotations — full annotation on UniProt →

Function. May act as a regulator of the protein kinase A (PKA) activity during embryonic development.

Subunit / interactions. Interacts with PRKAR1A; resulting in PKA activation.

Subcellular location. Golgi apparatus. Cytoplasm.

Tissue specificity. Ubiquitously expressed with higher expression in kidney, liver and placenta. Detected in embryonic kidney cells (HEK293 cells) (at protein level). Specifically expressed in liver.

Miscellaneous. Non-canonical splice sites for exon 9 and exon 10.

Similarity. Belongs to the PRRC1 family.

Isoforms (5)

UniProt IDNamesCanonical?
Q96M27-11yes
Q96M27-22
Q96M27-33
Q96M27-44
Q96M27-55

RefSeq proteins (2): NP_001273737, NP_570721* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR026533NTPase/PRRC1Domain
IPR026534PRRC1Family
IPR029001ITPase-like_famHomologous_superfamily

Pfam: PF01931

UniProt features (15 total): splice variant 6, region of interest 2, sequence conflict 2, compositionally biased region 2, modified residue 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q96M27-F168.930.42

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 209, 408

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 215 (showing top): RNGTGGGC_UNKNOWN, NKX25_02, MODULE_45, DARWICHE_SKIN_TUMOR_PROMOTER_DN, DARWICHE_PAPILLOMA_RISK_LOW_UP, DARWICHE_PAPILLOMA_RISK_HIGH_UP, DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN, MODULE_16, OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP, MODULE_239, GATA1_03, GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS, MORI_PLASMA_CELL_UP, GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE, ACEVEDO_LIVER_CANCER_UP

GO Biological Process (1): epithelial structure maintenance (GO:0010669)

GO Molecular Function (3): protein kinase A regulatory subunit binding (GO:0034237), identical protein binding (GO:0042802), protein binding (GO:0005515)

GO Cellular Component (2): cytoplasm (GO:0005737), Golgi apparatus (GO:0005794)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
tissue homeostasis1
protein kinase A binding1
protein binding1
binding1
intracellular anatomical structure1
cellular anatomical structure1
cytoplasm1
endomembrane system1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

658 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PRRC1SAR1AQ9NR31585
PRRC1MINAR2P59773507
PRRC1DNHD1Q96M86454
PRRC1SPMIP10Q6ZNM6418
PRRC1DNASE1L1P49184392
PRRC1NUDT5Q9UKK9384
PRRC1TEX36Q5VZQ5366
PRRC1CTXN3Q4LDR2360
PRRC1MINAR1Q9UPX6348
PRRC1C5orf63A6NC05348
PRRC1TTC22Q5TAA0338
PRRC1TRAPPC2P0DI81328
PRRC1SEC23AQ15436325
PRRC1TNRC18O15417323
PRRC1FKBP11Q9NYL4321

IntAct

52 interactions, top by confidence:

ABTypeScore
PLK1SPAG9psi-mi:“MI:0914”(association)0.790
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
SEC23ASEC24Dpsi-mi:“MI:0914”(association)0.690
HTTPRRC1psi-mi:“MI:0915”(physical association)0.670
YWHAGBLTP3Bpsi-mi:“MI:0914”(association)0.640
YWHAHBLTP3Bpsi-mi:“MI:0914”(association)0.570
PRRC1PIN1psi-mi:“MI:0915”(physical association)0.560
PRRC1SEC23Bpsi-mi:“MI:0915”(physical association)0.560
PIN1PRRC1psi-mi:“MI:0915”(physical association)0.560
SEC23BPRRC1psi-mi:“MI:0915”(physical association)0.560
PRRC1CDC5psi-mi:“MI:0915”(physical association)0.560
CDC5PRRC1psi-mi:“MI:0915”(physical association)0.560
PRRC1psi-mi:“MI:0915”(physical association)0.560
AP3D1psi-mi:“MI:0914”(association)0.460
TSG101PRRC1psi-mi:“MI:0407”(direct interaction)0.440
Plk1psi-mi:“MI:0915”(physical association)0.400
PRRC1psi-mi:“MI:0915”(physical association)0.370
HTTpsi-mi:“MI:0914”(association)0.350
apaNUDT21psi-mi:“MI:0914”(association)0.350

BioGRID (74): PRRC1 (Two-hybrid), PRRC1 (Two-hybrid), PRRC1 (Affinity Capture-MS), PRRC1 (Affinity Capture-MS), HNRNPA1 (Co-fractionation), NPEPL1 (Co-fractionation), PAFAH1B2 (Co-fractionation), PPIB (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PRRC1 (Co-fractionation), PSMG1 (Co-fractionation), RAB1A (Co-fractionation)

ESM2 similar proteins: A0A8M1NHK4, A3KFF6, A6H8J1, O49429, O80678, O80910, P12348, P55265, P94017, P97765, Q08B53, Q13434, Q32SG5, Q3T1I4, Q3TJZ6, Q3UMQ8, Q3UPH1, Q4R3M1, Q5F3N9, Q5FWT1, Q5R679, Q5XJA3, Q5Z8L1, Q66H68, Q6ICG8, Q6P870, Q7G6K7, Q7ZYB4, Q8AVN9, Q8LA32, Q8R478, Q8R4X3, Q93YP4, Q94JZ8, Q969T9, Q96M27, Q9C5P0, Q9C6S1, Q9D529, Q9FF15

Diamond homologs: A6H8J1, Q08B53, Q3T1I4, Q3UPH1, Q5F3I0, Q5XJA3, Q6P870, Q96M27

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

96 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance76
Likely benign5
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1579 predictions. Top by Δscore:

VariantEffectΔscore
5:127523457:T:Gacceptor_gain1.0000
5:127523458:A:AGacceptor_gain1.0000
5:127523459:G:GTacceptor_gain1.0000
5:127523459:GT:Gacceptor_gain1.0000
5:127523556:C:Gdonor_gain1.0000
5:127523579:T:TGdonor_gain1.0000
5:127523579:TTAGG:Tdonor_loss1.0000
5:127523580:TAGGT:Tdonor_loss1.0000
5:127523581:AGG:Adonor_loss1.0000
5:127523582:GGT:Gdonor_loss1.0000
5:127523583:GTAC:Gdonor_loss1.0000
5:127523584:T:Adonor_loss1.0000
5:127530397:G:GGdonor_gain1.0000
5:127533618:TTTA:Tacceptor_loss1.0000
5:127533619:TTA:Tacceptor_loss1.0000
5:127533620:TA:Tacceptor_loss1.0000
5:127533621:A:AGacceptor_gain1.0000
5:127533622:G:GAacceptor_gain1.0000
5:127533622:GA:Gacceptor_gain1.0000
5:127533622:GAA:Gacceptor_gain1.0000
5:127533622:GAAT:Gacceptor_gain1.0000
5:127533783:AAAAG:Adonor_loss1.0000
5:127533784:AAAGT:Adonor_loss1.0000
5:127533785:AA:Adonor_gain1.0000
5:127533786:AGT:Adonor_loss1.0000
5:127533787:G:Adonor_loss1.0000
5:127533787:GTGA:Gdonor_gain1.0000
5:127533788:T:Gdonor_loss1.0000
5:127533789:G:GTdonor_loss1.0000
5:127533790:AGT:Adonor_loss1.0000

AlphaMissense

2831 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
5:127526774:T:AI217N0.999
5:127530361:T:AI241N0.999
5:127530361:T:CI241T0.999
5:127530361:T:GI241S0.999
5:127530370:T:AL244Q0.999
5:127530370:T:CL244P0.999
5:127530382:T:CM248T0.999
5:127533752:C:AA296D0.999
5:127539053:G:CR312P0.999
5:127551750:G:AG391D0.999
5:127551812:T:AW412R0.999
5:127551812:T:CW412R0.999
5:127530373:A:GD245G0.998
5:127530382:T:GM248R0.998
5:127547820:T:AW343R0.998
5:127547820:T:CW343R0.998
5:127551743:T:AW389R0.998
5:127551743:T:CW389R0.998
5:127551749:G:CG391R0.998
5:127526771:T:CF216S0.997
5:127526774:T:GI217S0.997
5:127533722:T:AV286D0.997
5:127533761:C:AP299Q0.997
5:127533779:G:AG305E0.997
5:127551708:C:AA377D0.997
5:127551750:G:TG391V0.997
5:127551753:T:CL392P0.997
5:127526774:T:CI217T0.996
5:127530325:T:AV229E0.996
5:127530328:T:AL230H0.996

dbSNP variants (sampled 300 via entrez): RS1000133638 (5:127538455 T>C), RS1000140870 (5:127544095 A>G), RS1000223811 (5:127525941 G>C,T), RS1000405185 (5:127545077 C>A), RS1000525760 (5:127554639 C>A,T), RS1000559907 (5:127553092 C>A,T), RS1000629142 (5:127520714 A>C,G), RS1000632073 (5:127553483 T>A,C), RS1000691972 (5:127547364 T>A), RS1000768026 (5:127548760 C>T), RS1000794698 (5:127527382 A>G), RS1000819141 (5:127538801 A>C), RS1000903231 (5:127515955 C>T), RS1001140621 (5:127547001 T>C), RS1001145782 (5:127544861 G>A)

Disease associations

OMIM: gene MIM:621301 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009391_1080Metabolite levels8.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0010529ribose-5-phosphate measurement
EFO:0010530ribulose-5-phosphate measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

36 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, increases expression, affects cotreatment, increases methylation4
Dronabinolincreases expression2
Tobacco Smoke Pollutionaffects expression, increases expression2
Particulate Matterdecreases expression, increases abundance, increases expression2
aristolochic acid Idecreases expression1
bisphenol Faffects cotreatment, decreases expression1
dicrotophosincreases expression1
triphenyl phosphateaffects expression1
sodium arseniteincreases expression1
perfluorooctanoic aciddecreases expression1
zinc chromateincreases abundance, increases expression1
chromium hexavalent ionincreases abundance, increases expression1
perfluorooctane sulfonic acidincreases expression1
pentabromodiphenyl etherincreases expression1
nutlin 3affects cotreatment, increases secretion1
abrinedecreases expression1
2,2’,4,4’-tetrabromodiphenyl etherincreases expression1
Arsenic Trioxideincreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Acetaminophenincreases expression1
Air Pollutantsdecreases expression, increases abundance1
Benzo(a)pyreneincreases methylation1
Dactinomycinaffects cotreatment, increases secretion1
Dexamethasonedecreases expression, affects cotreatment1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Indomethacinaffects cotreatment, decreases expression1
Ivermectindecreases expression1
Dihydrotestosteroneincreases expression1
Thiramincreases expression1
Tretinoindecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.